Maryland’s Medicaid program now offers partial coverage of popular obesity drugs, with the state spending more than $68 ...

Results of the study indicate that Black women in the U.S., ages 66-75, saw the largest decrease in obesity between 2022-2023 ...

Some people are not taking weight-loss medications responsibly, the physician says, and don't realize their full implications ...

When you think of a top weight loss drug, chances are that Ozempic is the name that first comes to mind. Although it is ...

The secret agent in the decrease might be semaglutide, a GLP-1 receptor agonist that fuels popular weight loss drugs like ...

MERCK snagged a potential drug in the burgeoning market for obesity medications in a deal worth as much as US$2 billion. Read ...

Nestle is launching protein shots in the United States which it says help suppress appetite for people looking to shed pounds ...

Doctors might be slow to admit it, but Ozempic and other GLP-1 drugs are making dieting and exercise obsolete.

Biden officials recently proposed allowing Medicare to start covering GLP-1 medications to treat obesity. It's unclear ...

A few years ago, West Virginia, which has the highest obesity rate in the nation, quietly began a small and unusual pilot ...

Obesity dipped in U.S. adults last year for the first time in more than a decade, research found. That might be due, in part, ...

Merck & Co. snagged a potential drug in the burgeoning market for obesity medications in a deal worth as much as $2 billion.